Gangguan Somatoform
Published on September 10, 2026
Risk Factors
Female sex, lower socioeconomic status, history of childhood illness or trauma, comorbid anxiety/depression, poor doctor-patient communication, personality traits with high neuroticism
Etiology
Psychological conflicts and emotional distress are unconsciously converted into physical symptoms. There is no deliberate fabrication (distinguishing it from malingering and factitious disorder).
Presentation
Repeated, varied physical complaints with persistent requests for medical investigation, despite negative results and physician reassurance that no organic disease is found
Classic Exam
No objective findings that explain the severity or pattern of complaints. Physical exam is characteristically normal or reveals only non-contributory incidental findings.
Diagnostics
All laboratory, imaging, and procedural investigations return negative or normal. The diagnosis is clinical, based on pattern recognition of the complaint history and behavioral criteria.
Management
Establishing a single primary physician, scheduled regular visits (not symptom-driven), validation of suffering without reinforcing illness behavior, cognitive-behavioral therapy (CBT), and cautious use of antidepressants for comorbid anxiety/depression
01Pathophysiology
Somatoform disorder is rooted in the concept that psychological distress is expressed through the body rather than through conscious emotional awareness. The patient genuinely experiences physical symptoms, but these symptoms cannot be fully explained by any identifiable medical condition, substance use, or structural abnormality.
The central pathophysiological mechanism involves a disruption in how the brain processes and interprets internal bodily signals, a concept known as abnormal interoception. In these patients, the threshold for perceiving normal physiological sensations (such as bowel motility, heartbeat, or muscle tension) is lowered. Normal signals are amplified and interpreted as painful or threatening. This is called somatosensory amplification.
There is also a strong component of alexithymia, where the patient has difficulty identifying, describing, or processing their own emotions. When emotional conflicts (such as interpersonal stress, grief, or unresolved trauma) arise, the patient lacks the psychological vocabulary to process them. Instead, these emotions are channeled into somatic pathways, producing real, distressing physical symptoms.
According to the PPDGJ-III, a hallmark behavioral feature is that the patient actively denies and refuses ("menyangkal dan menolak") the possibility that their physical complaints could be linked to psychological problems or life conflicts, even when they simultaneously exhibit signs of anxiety and depression. This denial is not strategic or manipulative; it reflects a genuine lack of insight into the mind-body connection.
The consequence is a repeating cycle: the patient experiences symptoms, seeks medical evaluation, receives negative results, rejects the reassurance, and then seeks another doctor or another test. This cycle generates frustration and mutual misunderstanding between the doctor and the patient, as highlighted in the PPDGJ-III.
02Classification and Clinical Manifestation
Subtype | Core Clinical Feature | Duration Requirement | Key Distinguishing Point |
|---|---|---|---|
Somatization Disorder | Multiple, varied, and recurrent physical complaints across different organ systems that cannot be explained by organic disease | At least 2 years | Patient refuses reassurance from multiple doctors; functional disability in social and family life is present |
Undifferentiated Somatoform Disorder | Multiple, varied, and persistent physical complaints, but the full clinical picture of somatization disorder is not met | Less rigid, but complaints are persistent | The complaints are real and varied, but either the number, the duration, or the associated disability does not reach the threshold for somatization disorder. Organic and psychogenic causes remain unconfirmed. |
Hypochondriacal Disorder | Persistent belief (not a delusion) that one has at least one serious physical disease, OR a persistent preoccupation with a presumed deformity (body dysmorphic variant) | Persistent | The emphasis is on the belief and fear of disease, not the symptoms themselves. The patient refuses to accept negative findings. This is a cognitive distortion, not a psychotic delusion. |
Somatoform Autonomic Dysfunction | Symptoms attributed to organs under autonomic nervous system control (heart, GI tract, respiratory system, genitourinary system), with objective signs of autonomic arousal (palpitations, sweating, tremor, flushing) | Persistent and distressing | Combines (a) objective autonomic signs, (b) subjective non-characteristic organ complaints, (c) preoccupation with serious organ disease, and (d) no structural/functional abnormality found on investigation |
Persistent Somatoform Pain Disorder | Severe, distressing, and persistent pain that cannot be fully explained by physiological processes or a physical disorder | Persistent | Pain occurs in the context of emotional conflict or psychosocial problems sufficient to be considered the primary cause. Results in increased attention and support from personal and medical circles. |
Other Somatoform Disorders | Complaints that are not mediated through the autonomic nervous system and are limited to one body part or system | Variable | Differs from somatization and undifferentiated somatoform disorder because the complaints are localized, not multiple and shifting. No tissue damage is present. Examples include globus hystericus, psychogenic torticollis, psychogenic pruritus. |
03Diagnostic Workup
Test Category | Purpose | Expected Finding |
|---|---|---|
Complete history with symptom inventory | Best initial step. Identify the pattern: multiple complaints, multiple doctors, long duration, negative prior workups | History reveals the classic pattern of varied, unexplained complaints over at least 2 years (for somatization disorder) |
Targeted physical examination | Rule out organic disease for the current presenting complaint | Normal or findings that do not explain the severity/pattern of complaints |
Basic laboratory panel (CBC, metabolic panel, thyroid function, ESR/CRP) | Exclude common organic mimics (thyroid disease, anemia, inflammatory conditions) | Normal |
Directed imaging or procedures (if clinically indicated for a new complaint) | Avoid both over-investigation and dangerous under-investigation | Normal or incidental, non-explanatory findings |
Psychiatric screening tools (PHQ-9, GAD-7, PHQ-15 for somatic symptom burden) | Identify comorbid depression and anxiety, quantify somatic symptom severity | Often positive for anxiety and/or depression, even if patient denies psychological distress |
Review of prior medical records | Critical step to establish the longitudinal pattern of doctor visits and negative workups | Pattern of repeated consultations, negative investigations, and refusal of reassurance |
The diagnostic approach to somatoform disorder is fundamentally clinical and longitudinal. There is no single confirmatory laboratory test. The diagnosis is made by recognizing the pattern described in the PPDGJ-III criteria.
The best initial step is always a thorough history. You are looking for the combination of (a) multiple, recurrent physical complaints, (b) a long history of medical consultations with negative results, (c) the patient's refusal to accept that no organic disease is present, and (d) evidence of functional impairment. For somatization disorder, the PPDGJ-III requires that this pattern has been present for at least 2 years.
A critical clinical skill being tested is knowing when to stop investigating. Once a reasonable workup has excluded dangerous or treatable organic conditions, ordering further tests reinforces the patient's illness behavior and worsens the cycle. However, new symptoms that represent a genuinely new clinical presentation should still be appropriately evaluated. The trap is at both extremes: dismissing a real new symptom as "just somatoform" (anchoring bias) or endlessly investigating every complaint.
For hypochondriacal disorder, the diagnostic emphasis shifts from symptoms to beliefs. The examiner will present a patient who is convinced they have a serious disease and will not accept reassurance. The key discriminator from a delusional disorder is that the hypochondriacal belief is not of delusional intensity (the PPDGJ-III notes: "tidak sampai waham").
For somatoform autonomic dysfunction, the diagnosis requires the presence of objective autonomic signs (palpitations, sweating, tremor, flushing) alongside subjective complaints referred to an organ system, with no structural abnormality found. This is the only somatoform subtype where you expect to find some objective physical signs on examination, though these are autonomic arousal signs, not signs of organ damage.
04Management and Treatment
phase | Intervention | Details |
|---|---|---|
Foundation | Establish a single primary physician | Prevents doctor shopping; all consultations are routed through one provider |
Foundation | Scheduled regular visits | Visits are time-based (e.g., every 2 to 4 weeks), NOT symptom-driven. This decouples medical attention from symptom reporting. |
Foundation | Validation without reinforcement | Acknowledge the patient's suffering as real. Do not say "it's all in your head." But do not order unnecessary tests to placate. |
Psychotherapy | Cognitive-Behavioral Therapy (CBT) | First-line psychotherapy. Targets catastrophic interpretation of bodily sensations, illness beliefs, and avoidance behaviors. Typical course: 8 to 16 sessions. |
Pharmacotherapy | SSRIs (e.g., fluoxetine 20 mg/day, sertraline 50 mg/day) or SNRIs (e.g., venlafaxine 75 to 150 mg/day, duloxetine 60 mg/day) | Used when comorbid depression or anxiety is present, or for persistent somatoform pain disorder. Start low, go slow. Duration: at least 6 to 12 months before reassessment. |
Pharmacotherapy | Low-dose tricyclic antidepressants (e.g., amitriptyline 10 to 25 mg at bedtime) | Useful for persistent somatoform pain disorder due to analgesic and sleep-promoting properties. Not first-line for other subtypes. |
Avoidance | Do NOT prescribe benzodiazepines long-term | Risk of dependence. Short-term use only for acute anxiety crises if absolutely necessary. |
Avoidance | Do NOT prescribe opioids for somatoform pain | High risk of dependence and reinforcement of pain behavior. |
Avoidance | Minimize unnecessary investigations and specialist referrals | Each new test or referral reinforces illness behavior and the belief that something organic is being missed. |
The next best step after diagnosis is always to establish the therapeutic alliance by scheduling regular, brief, non-symptom-contingent visits. This is more important than any medication and is the most commonly tested management principle for somatoform disorder.
The rationale for CBT is directly linked to the pathophysiology. The patient misinterprets normal bodily sensations as dangerous. CBT teaches the patient to recognize this cognitive distortion, reattribute the sensation to benign causes, and gradually reduce avoidance behaviors that maintain the symptom cycle.
For persistent somatoform pain disorder, the PPDGJ-III highlights that the pain emerges in the context of emotional conflict or psychosocial problems. The management must address the underlying psychosocial stressor alongside pharmacological pain management. Duloxetine (60 mg/day) has the strongest evidence base for this subtype because of its dual action on serotonin and norepinephrine pathways involved in descending pain modulation.
A contraindication to be aware of: TCAs should be used cautiously in patients with cardiac history (QT prolongation risk) and in elderly patients (anticholinergic side effects). SSRIs are generally preferred in these populations.
05Differential Diagnosis and Distractors
Differential | Why It Looks Similar | Key Discriminator |
|---|---|---|
Generalized Anxiety Disorder (GAD) | Both present with multiple somatic complaints (headaches, muscle tension, GI upset) and anxiety | In GAD, the patient recognizes the anxiety and reports worry as the primary problem. In somatoform disorder, the patient insists the problem is physical and denies psychological distress. |
Major Depressive Disorder with somatic features | Depression can present with fatigue, pain, appetite changes, and sleep disturbance, mimicking somatic complaints | In depression, mood symptoms (sadness, anhedonia, guilt) are present and often acknowledged. In somatoform disorder, the patient focuses exclusively on physical complaints and may deny feeling depressed even when screening tools are positive. |
Panic Disorder | Autonomic symptoms (palpitations, chest pain, sweating, dyspnea) overlap with somatoform autonomic dysfunction | Panic disorder presents as discrete, episodic attacks with a clear onset and offset. Somatoform autonomic dysfunction involves persistent and continuous autonomic complaints, not episodic surges. |
Illness Anxiety Disorder (Hypochondriasis without significant somatic symptoms) | Both involve excessive health-related fear | In classic hypochondriacal disorder per PPDGJ-III, there may be some somatic symptoms. In illness anxiety disorder (DSM-5 construct), somatic symptoms are minimal or absent, and the preoccupation is purely cognitive. The PPDGJ-III does not make this distinction and groups both under hypochondriacal disorder. |
Conversion Disorder (Dissociative Motor/Sensory Disorder) | Both involve physical symptoms without organic explanation | Conversion disorder presents with neurological symptoms (paralysis, blindness, seizures, anesthesia) that suggest a neurological lesion. Somatoform disorder presents with general medical symptoms (pain, GI complaints, fatigue) not limited to the neurological system. In PPDGJ-III, conversion disorder is classified under dissociative disorders, not somatoform disorders. |
Factitious Disorder | Both involve symptoms without organic disease | In factitious disorder, the patient intentionally produces or feigns symptoms for the psychological gain of assuming the sick role. In somatoform disorder, the symptoms are not intentionally produced. The patient genuinely believes they are ill. |
Malingering | Physical complaints without organic basis | In malingering, the patient consciously fabricates symptoms for an external incentive (financial compensation, avoiding work, legal advantage). In somatoform disorder, there is no external incentive, and the patient is not faking. |
Delusional Disorder, somatic type | Patient has a fixed belief about having a disease or physical defect | In delusional disorder, the belief is of delusional intensity (bizarre, unshakable, and immune to any evidence). In hypochondriacal disorder per PPDGJ-III, the belief is a strong conviction but does not reach delusional proportions ("tidak sampai waham"). The patient can, at least momentarily, entertain the possibility of being wrong. |
06Traps and High-Yield Pearls
The most common way students lose points on somatoform disorder questions is by confusing it with conditions where the patient is aware of or in control of symptom production. The fundamental distinction tested again and again is the axis of awareness and intent: in somatoform disorder, the patient is neither aware that the symptoms are psychologically generated nor are they intentionally producing them. This separates somatoform disorder from factitious disorder (intentional production, psychological motivation) and malingering (intentional production, external motivation). If the vignette contains any hint of secondary gain, financial incentive, or inconsistency in symptom reporting when the patient believes they are not being observed, the answer is not somatoform disorder.
A second common trap involves the 2-year duration criterion for somatization disorder. Many vignettes will describe a patient with multiple somatic complaints but a duration of only 6 months or 1 year. In this case, the correct answer per PPDGJ-III criteria is undifferentiated somatoform disorder, not somatization disorder. Students who do not remember the duration requirement will select the wrong subtype.
A third trap targets the distinction between hypochondriacal disorder and delusional disorder. Both involve a persistent belief about having a disease. The discriminator is intensity: hypochondriacal beliefs are overvalued ideas that the patient can briefly question, while somatic delusions are completely fixed and unshakable. If the vignette describes a patient who "cannot be convinced" despite all evidence, but the belief is plausible (e.g., "I have cancer"), lean toward hypochondriacal disorder. If the belief is bizarre (e.g., "my organs are rotting and emitting a smell that others can detect"), lean toward delusional disorder.
Finally, the core competency being tested is whether you can recognize the pattern over the noise: a patient with a long history, multiple complaints, multiple doctors, negative workups, refusal of reassurance, and denial of psychological etiology. Once you see this pattern, the diagnosis is somatoform disorder. The next best step is always to validate, not investigate further, and to establish a consistent therapeutic relationship with one physician.